These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 34245113)

  • 1. Multidrug-resistant organisms: A significant cause of severe sepsis in pediatric intestinal and multi-visceral transplantation.
    Alcamo AM; Trivedi MK; Dulabon C; Horvat CM; Bond GJ; Carcillo JA; Green M; Michaels MG; Aneja RK
    Am J Transplant; 2022 Jan; 22(1):122-129. PubMed ID: 34245113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe Sepsis in Pediatric Liver Transplant Patients: The Emergence of Multidrug-Resistant Organisms.
    Alcamo AM; Alessi LJ; Vehovic SN; Bansal N; Bond GJ; Carcillo JA; Green M; Michaels MG; Aneja RK
    Pediatr Crit Care Med; 2019 Jul; 20(7):e326-e332. PubMed ID: 31094887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of multidrug resistant organism acquisition in an adult specialist burns service: a retrospective review.
    Cleland H; Tracy LM; Padiglione A; Stewardson AJ
    Antimicrob Resist Infect Control; 2022 Jun; 11(1):82. PubMed ID: 35698209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and risk factors associated with multi-drug resistant organisms (MDRO) carriage among pediatric patients at the time of admission in a tertiary care hospital of a developing country. A cross-sectional study.
    Qureshi S; Maria N; Zeeshan M; Irfan S; Qamar FN
    BMC Infect Dis; 2021 Jun; 21(1):547. PubMed ID: 34107903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mortality incidence among critically ill burn patients infected with multidrug-resistant organisms: A retrospective cohort study.
    Ellithy M; Mitwally H; Saad M; Mathias R; Shaukat A; Elzeer H; Hassan Koya S; Mahmood Z; Gazwi K
    Scars Burn Heal; 2021; 7():20595131211015133. PubMed ID: 34104480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcomes of intestinal transplant recipients colonized with multidrug-resistant organisms: a retrospective study.
    Simkins J; Morris MI; Camargo JF; Vianna R; Beduschi T; Abbo LM
    Transpl Int; 2017 Sep; 30(9):924-931. PubMed ID: 28544183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infections due to multidrug-resistant organisms following heart transplantation: Epidemiology, microbiology, and outcomes.
    Bhatt PJ; Ali M; Rana M; Patel G; Sullivan T; Murphy J; Pinney S; Anyanwu A; Huprikar S; Taimur S
    Transpl Infect Dis; 2020 Feb; 22(1):e13215. PubMed ID: 31765045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology, Risk Factors and Outcome Due to Multidrug Resistant Organisms in Paediatric Liver Transplant Patients in the Era of Antimicrobial Stewardship and Screening.
    Verma A; Vimalesvaran S; Dhawan A
    Antibiotics (Basel); 2022 Mar; 11(3):. PubMed ID: 35326850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and Outcomes of Multi-Drug Resistant Blood Stream Infections Among Nursing Home Residents Admitted to an Acute Care Hospital.
    Aliyu S; McGowan K; Hussain D; Kanawati L; Ruiz M; Yohannes S
    J Intensive Care Med; 2022 Apr; 37(4):565-571. PubMed ID: 33938320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence, risk factors and clinical outcome of multidrug-resistant organisms after heart transplantation.
    Hatzianastasiou S; Vlachos P; Stravopodis G; Elaiopoulos D; Koukousli A; Papaparaskevas J; Chamogeorgakis T; Papadopoulos K; Soulele T; Chilidou D; Kolovou K; Gkouziouta A; Bonios M; Adamopoulos S; Dimopoulos S
    World J Transplant; 2024 Jun; 14(2):93567. PubMed ID: 38947964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics and epidemiology of sepsis in the neonatal intensive care unit in the era of multi-drug resistant organisms: A retrospective review.
    Yusef D; Shalakhti T; Awad S; Algharaibeh H; Khasawneh W
    Pediatr Neonatol; 2018 Feb; 59(1):35-41. PubMed ID: 28642139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of American Thoracic Society guidelines in predicting infection or colonization with multidrug-resistant organisms in critically ill patients.
    Xie J; Ma X; Huang Y; Mo M; Guo F; Yang Y; Qiu H
    PLoS One; 2014; 9(3):e89687. PubMed ID: 24647408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-drug resistant organism infections in a medical ICU: Association to clinical features and impact upon outcome.
    Magira EE; Islam S; Niederman MS
    Med Intensiva (Engl Ed); 2018 May; 42(4):225-234. PubMed ID: 29033075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes after Surgery among Patients Diagnosed with One or More Multi-Drug-Resistant Organisms.
    Gupta A; Tennakoon L; Spain DA; Forrester JD
    Surg Infect (Larchmt); 2021 Sep; 22(7):722-729. PubMed ID: 33471591
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical impact of colonization with multidrug-resistant organisms on outcome after allogeneic stem cell transplantation in patients with acute myeloid leukemia.
    Scheich S; Lindner S; Koenig R; Reinheimer C; Wichelhaus TA; Hogardt M; Besier S; Kempf VAJ; Kessel J; Martin H; Wilke AC; Serve H; Bug G; Steffen B
    Cancer; 2018 Jan; 124(2):286-296. PubMed ID: 28960264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Airway multidrug-resistant organisms in a population of tracheostomy and chronic ventilator-dependent children at a tertiary care pediatric hospital.
    Havens TN; Rosen DA; Rivera-Spoljaric K
    Pediatr Pulmonol; 2023 Jan; 58(1):26-34. PubMed ID: 36100968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hematopoietic stem-cell transplantation in a zoo of multidrug-resistant organisms: Data from a cancer center in eastern India.
    Ghosh S; Bhattacharya S; Goel G; Deshmukh RA; Javed R; Roychowdhury M; Sinha S; De MS; Nag A; Kumar J; Bhave SJ; Nair R; Chandy M
    Transpl Infect Dis; 2023 Nov; 25 Suppl 1():e14072. PubMed ID: 37260056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance patterns and outcomes in intensive care unit (ICU)-acquired pneumonia. Validation of European Centre for Disease Prevention and Control (ECDC) and the Centers for Disease Control and Prevention (CDC) classification of multidrug resistant organisms.
    Martin-Loeches I; Torres A; Rinaudo M; Terraneo S; de Rosa F; Ramirez P; Diaz E; Fernández-Barat L; Li Bassi GL; Ferrer M
    J Infect; 2015 Mar; 70(3):213-22. PubMed ID: 25445887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bloodstream infections in older population: epidemiology, outcome, and impact of multidrug resistance.
    de Laroche M; Fellous L; Salomon E; Saadeh D; Duran C; Bouchand F; Lequintrec JL; Teillet L; Gaillard JL; Seridi Z; Michelon H; Dinh A
    Eur J Clin Microbiol Infect Dis; 2021 Aug; 40(8):1665-1672. PubMed ID: 33694038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial resistance and recurrent bacterial urinary tract infections in hospitalized patients following kidney transplantation: A single-center experience.
    Greissman S; Mattiazzi A; Mendoza M; Natori Y; Grady M; Quinonez J; Zukerman R; Camargo JF; Morris MI; Simkins J; Guerra G; Abbo LM
    Transpl Infect Dis; 2020 Aug; 22(4):e13337. PubMed ID: 32452596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.